Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic priorities for the year 2025 and anticipated milestones in a recent press release on ...
The 43 rd Annual Healthcare J.P. Morgan Healthcare Conference kicked off in San Francisco, California earlier this week. Notable executives from analytical science companies were invited to speak ...
What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...
The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public ...
San Francisco law enforcement and city leaders are gearing up for a big month ahead and are warning people to be on alert for ...
Reminders of the killing of UnitedHealthcare CEO Brian Thompson were everywhere at this year's J.P. Morgan conference.
Healthcare J.P. Morgan Healthcare Conference kicked off in San Francisco earlier this week. Here’s what top executives from ...
The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...
Highlights from the third day included information about Quanterix's new Simoa One platform, expected to launch at the end of ...
SAN FRANCISCO — At the JP Morgan Healthcare Conference here on Wednesday, Myriad Genetics CEO Paul Diaz provided preliminary Q4 and full-year 2024 financial results, as well as full-year 2025 guidance ...
Medicare Advantage (MA) insurers Alignment Healthcare and Clover Health both reported increased membership growth ahead of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback